Type 2 Diabetes

Diabetes is one of the four major types of noncommunicable diseases (NCDs) that make the largest contribution to morbidity and mortality worldwide. The prevalence of diabetes is increasing in Bangladesh in both urban and rural areas....

Novo Nordisk announced the results of the CAPTURE study, a global non-interventional study to uncover the prevalence of cardiovascular disease and risk and its management in people living with type 2 diabetes. The study, the first...

A new ‘global atlas’ study published in Diabetologia is the first to identify insomnia as a risk factor associated with increased risk of developing type 2 diabetes (T2D). The study identifies 34 risk factors that are...

Healthcare Pharmaceuticals Ltd. (HPL) and Eli Lilly and Company on August 7th, declared the launch of Trulicity® (dulaglutide) in Bangladesh. Trulicity® is the first once-weekly, injectable medication designed to improve blood sugar control in adults with...

New research presented at this year’s annual meeting of the European Association for the Study of Diabetes (EASD) in Barcelona, Spain shows that specialist analysis of the lens in the eye can predict patients with type...

Obesity is linked to a nearly 6-fold increased risk of developing type 2 diabetes (T2D), with high genetic risk and unfavorable lifestyle also increasing risk but to a much lesser extent. These are the conclusions of...

Short stature is associated with a higher risk of type 2 diabetes, according to a new study in Diabetologia (the journal of the European Association for the Study of Diabetes). Tall stature is associated with a...

New research published in Diabetologia (the journal of the European Association for the Study of Diabetes ) shows that non-invasive measurement of skin autofluorescence (SAF) can predict future risk of type 2 diabetes, cardiovascular disease (CVD)...

The amount of insulin needed to effectively treat type 2 diabetes will rise by more than 20% worldwide over the next 12 years, but without major improvements in access, insulin will be beyond the reach of...

New research published in Diabetologia shows that in women, high levels of the hormone prolactin in the blood (but within the physiological range) are associated with a lower risk of developing type 2 diabetes (T2D). The...